Release date: 7/31/24
Expiration date: 7/30/26
Estimated Time of Completion: 2 hours
Description
Session Agenda
Update in Treatment of Atopic Dermatitis
Raj Chovatiya, MD, PhD, Rosalind Franklin University Chicago Medical School
Update in Treatment of Inflammatory Alopecias
Melissa Piliang, MD, Cleveland Clinic
Update in Treatment of Chronic Urticaria
James Fernandez, MD, PhD, Cleveland Clinic
Update in Treatment of Hidradenitis Suppurativa
Amit Garg, MD, Hofstra/Northwell
Present State and Future of Medical Dermatology: Insights from Tenures as Editor-in-Chief of the JAAD and AAD President *
Dirk Elston, MD, Medical University of South Carolina
Update in Treatment of Psoriasis Vulgaris
Anthony Fernandez, MD, PhD, Cleveland Clinic
Update in Treatment of Psoriatic Arthritis
M. Elaine Husni, MD, MPH, Cleveland Clinic
Description
Watch Medical Dermatology Therapy Update Webcast Series, recorded from Medical Dermatology Therapy Update III: Autoimmune, Chronic Inflammatory, and Advanced Malignant Diseases.
This CE-certified educational series offers a unique opportunity to update your knowledge and understanding of both traditional and new therapeutic strategies for a range of critically important medical dermatologic conditions, including rheumatology-dermatology overlap diseases, atopic dermatitis, advanced melanoma and other cutaneous malignancies, urticaria, sarcoidosis, hidradenitis suppurativa, autoimmune bullous disease, cutaneous lymphomas, alopecia areata, and psoriatic disease.
Learning Objectives
- Summarize strategies to optimize an interprofessional team approach to caring for patients with complex medical dermatologic diseases.
- Identify key components of clear and effective communication.
- Discuss the role of communication and power dynamics on the process of driving change.
- Examine the influential factors that contribute to persuasive communication. Examine current and future approaches to phenotyping patients and the utilization of laboratory testing in CSU.
- Describe the rationale for a Shared Medical Appointment (SMA).
- Identify the clinical situations where an SMA may be ideally implemented.
- Discuss our experience instituting the SMA for the patch testing consultation appointment.
Target Audience
The online series is designed for physicians, pharmacists, nurses, advanced practice clinicians, physician assistants, residents, fellows and allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine, and general practice.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this internet enduring activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Accreditation Council of Pharmacy Education (ACPE)
Cleveland Clinic Center for Continuing Education designates this knowledge-based activity for a maximum of 2.0 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Universal Activity Number List:
JA0000192-0000-24-548-H01-P
JA0000192-0000-24-548-H01-T
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Director
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Planning Committee
Madeline June, CNP
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Sean Krohn, PharmD
Specialty Pharmacy
Cleveland Clinic
Cleveland, OH
Jessica Wampleman, RN
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Clara Wilson, PA-C
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Faculty
John Anthony, MD
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Cecile Foshee, PhD
Office of Interprofessional Learning & QPS
Cleveland Clinic
Cleveland, OH
Jennifer Jones, CNP
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Joan Tamburro, DO
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Jessica Wampleman, RN
Department of Dermatology
Cleveland Clinic Cleveland Clinic
Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| John Anthony, MD |
|
Johnson & Johnson
Eli Lilly
Novartis
Regeneron
Nestle Health Sciences
3M
Illumina, Inc.
Google LLC
Apple Inc.
Life Sciences, subsidiary of Alphabet
Intuitive Surgical Inc.
Teladoc
Guardant
Amazon
NVIDIA
Intellia |
Ownership interest (stock, stock options in a publicly owned company) |
| Anthony P. Fernandez, MD, PhD |
|
Boehringer Ingelheim
UCB, Inc. |
Consulting |
Bristol-Myers Squibb Co.
Novartis
Mallinckrodt Inc.
Biogen Inc. |
Consulting
Teaching and Speaking |
Pfizer, Inc. |
Other activities from which remuneration is received or expected: awarded a grant to fund a medical dermatology fellowship position
Research: PI |
Abbvie Pharmaceuticals |
Consulting
Advisor or review panel participant
Teaching and Speaking |
Kyowa Kirin |
Teaching and Speaking |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Cecile M. Foshee, PhD
Jennifer Jones, CNP
Madeline June, CNP
Sean Krohn, PharmD
Joan Tamburro, DO
Jessica Wampleman, RN
Clara Wilson, PA-C
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Sun Pharmaceutical Industries, Inc.
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Department of Dermatology.
